HLA-B*14:02-Restricted Env-Specific CD8+ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection
暂无分享,去创建一个
J. Goedert | M. Carrington | B. Walker | Y. Qi | J. Fellay | S. Buus | Jeffrey N. Martin | Steven Wolinsky | O. Yang | P. Goulder | D. Haas | C. Willberg | S. Deeks | J. Martinson | A. Sáez-Cirión | Huabiao Chen | P. Matthews | M. Tsai | Maureen P. Martin | A. Piechocka-Trocha | Fabian Chen | E. Leitman | L. Riddell | Jeffrey N. Martin
[1] D. Follmann,et al. CD8+ T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types , 2014, EBioMedicine.
[2] Angela R. McLean,et al. Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence , 2014, Proceedings of the National Academy of Sciences.
[3] P. Goulder,et al. Impact of HLA-B*35 subtype differences on HIV disease outcome in Mexico , 2014, AIDS.
[4] Des C. Jones,et al. LILRB2 Interaction with HLA Class I Correlates with Control of HIV-1 Infection , 2014, PLoS genetics.
[5] Todd M. Allen,et al. How a single patient influenced HIV research--15-year follow-up. , 2014, The New England journal of medicine.
[6] J. Frelinger,et al. Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance. , 2013, Transplant immunology.
[7] Jessica Prince,et al. Selection bias at the heterosexual HIV-1 transmission bottleneck , 2013, Science.
[8] C. Rouzioux,et al. Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers , 2013, Journal of Virology.
[9] N. Frahm,et al. Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. , 2013, The Journal of infectious diseases.
[10] Klaus Schulten,et al. Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics , 2013, Nature.
[11] B. Clotet,et al. Expansion of antibody secreting cells and modulation of neutralizing antibody activity in HIV infected individuals undergoing structured treatment interruptions , 2013, Journal of Translational Medicine.
[12] David Heckerman,et al. Frequent and Variable Cytotoxic-T-Lymphocyte Escape-Associated Fitness Costs in the Human Immunodeficiency Virus Type 1 Subtype B Gag Proteins , 2013, Journal of Virology.
[13] J. Prado,et al. Early Antigen Presentation of Protective HIV-1 KF11Gag and KK10Gag Epitopes from Incoming Viral Particles Facilitates Rapid Recognition of Infected Cells by Specific CD8+ T Cells , 2012, Journal of Virology.
[14] Todd M. Allen,et al. Vaccine-induced CD8+ T cells control AIDS virus replication , 2012, Nature.
[15] B. Walker,et al. HIV and HLA class I: an evolving relationship. , 2012, Immunity.
[16] Andrew K. Sewell,et al. Differential Clade-Specific HLA-B*3501 Association with HIV-1 Disease Outcome Is Linked to Immunogenicity of a Single Gag Epitope , 2012, Journal of Virology.
[17] T. Ndung’u,et al. HIV control through a single nucleotide on the HLA-I locus , 2012, Journal of Virology.
[18] Todd M. Allen,et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection , 2012, Nature Immunology.
[19] David Heckerman,et al. Correlates of Protective Cellular Immunity Revealed by Analysis of Population-Level Immune Escape Pathways in HIV-1 , 2012, Journal of Virology.
[20] D. Heckerman,et al. CTL Responses of High Functional Avidity and Broad Variant Cross-Reactivity Are Associated with HIV Control , 2012, PloS one.
[21] B. Walker,et al. HLA-B*57 Micropolymorphism Shapes HLA Allele-Specific Epitope Immunogenicity, Selection Pressure, and HIV Immune Control , 2011, Journal of Virology.
[22] D. Heckerman,et al. HLA-A*7401–Mediated Control of HIV Viremia Is Independent of Its Linkage Disequilibrium with HLA-B*5703 , 2011, The Journal of Immunology.
[23] Jeffrey N. Martin,et al. A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers , 2011, PloS one.
[24] O. Yang,et al. Antiviral Activity of Human Immunodeficiency Virus Type 1 Gag-Specific Cytotoxic T Lymphocyte Targeting Is Not Necessarily Intrinsically Superior to Envelope Targeting , 2010, Journal of Virology.
[25] Jack T Stapleton,et al. The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.
[26] S. Buus,et al. Efficacious Early Antiviral Activity of HIV Gag- and Pol-Specific HLA-B*2705-Restricted CD8+ T Cells , 2010, Journal of Virology.
[27] D. Heckerman,et al. Additive Contribution of HLA Class I Alleles in the Immune Control of HIV-1 Infection , 2010, Journal of Virology.
[28] Mark Connors,et al. Long-term nonprogressive disease among untreated HIV-infected individuals: clinical implications of understanding immune control of HIV. , 2010, JAMA.
[29] A. Sáez-Cirión,et al. Ex vivo T cell–based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses , 2010, Nature Protocols.
[30] T. Kepler,et al. Toxin-Coupled MHC Class I Tetramers Can Specifically Ablate Autoreactive CD8+ T Cells and Delay Diabetes in Nonobese Diabetic Mice , 2010, The Journal of Immunology.
[31] R. Ahmed,et al. T‐cell reconstitution without T‐cell immunopathology in two models of T‐cell‐mediated tissue destruction , 2009, Immunology.
[32] D. Watkins,et al. Infection with “Escaped” Virus Variants Impairs Control of Simian Immunodeficiency Virus SIVmac239 Replication in Mamu-B*08-Positive Macaques , 2009, Journal of Virology.
[33] C. Hallahan,et al. Defective Human Immunodeficiency Virus-Specific CD8+ T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy , 2009, Journal of Virology.
[34] B. Autran,et al. Antigen sensitivity is a major determinant of CD8+ T-cell polyfunctionality and HIV-suppressive activity. , 2009, Blood.
[35] C. Rouzioux,et al. Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses1 , 2009, The Journal of Immunology.
[36] Todd M. Allen,et al. HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphocyte Recognition , 2009, Journal of Virology.
[37] B. Walker,et al. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients , 2009, The Journal of experimental medicine.
[38] Eric J. Arts,et al. Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response , 2009, PLoS pathogens.
[39] Todd M. Allen,et al. Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T Lymphocytes , 2009, Journal of Virology.
[40] Bin Li,et al. HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition , 2008, Journal of Virology.
[41] C. Hallahan,et al. Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. , 2008, Immunity.
[42] D. Heckerman,et al. Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.
[43] A. Hughes,et al. Comprehensive Immunological Evaluation Reveals Surprisingly Few Differences between Elite Controller and Progressor Mamu-B*17-Positive Simian Immunodeficiency Virus-Infected Rhesus Macaques , 2008, Journal of Virology.
[44] C. Sylvester-Hvid,et al. One-Pot, Mix-and-Read Peptide-MHC Tetramers , 2008, PloS one.
[45] D. Heckerman,et al. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure. , 2008, AIDS research and human retroviruses.
[46] David A. Price,et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.
[47] Todd M. Allen,et al. Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication , 2007, Journal of Virology.
[48] Todd M. Allen,et al. Escape and Compensation from Early HLA-B57-Mediated Cytotoxic T-Lymphocyte Pressure on Human Immunodeficiency Virus Type 1 Gag Alter Capsid Interactions with Cyclophilin A , 2007, Journal of Virology.
[49] D. Watkins,et al. Pol-Specific CD8+ T Cells Recognize Simian Immunodeficiency Virus-Infected Cells Prior to Nef-Mediated Major Histocompatibility Complex Class I Downregulation , 2007, Journal of Virology.
[50] E. Rosenberg,et al. Recognition of a Defined Region within p24 Gag by CD8+ T Cells during Primary Human Immunodeficiency Virus Type 1 Infection in Individuals Expressing Protective HLA Class I Alleles , 2007, Journal of Virology.
[51] Asier Sáez-Cirión,et al. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.
[52] J. Frelinger,et al. Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin. , 2007, Blood.
[53] D. Watkins,et al. Gag-Specific CD8+ T Lymphocytes Recognize Infected Cells before AIDS-Virus Integration and Viral Protein Expression1 , 2007, The Journal of Immunology.
[54] F. Pereyra,et al. Control of Human Immunodeficiency Virus Type 1 Is Associated with HLA-B*13 and Targeting of Multiple Gag-Specific CD8+ T-Cell Epitopes , 2007, Journal of Virology.
[55] M. Hoelscher,et al. CD8 T-Cell Recognition of Multiple Epitopes within Specific Gag Regions Is Associated with Maintenance of a Low Steady-State Viremia in Human Immunodeficiency Virus Type 1-Seropositive Patients , 2006, Journal of Virology.
[56] M. McElrath,et al. Preservation of T Cell Proliferation Restricted by Protective HLA Alleles Is Critical for Immune Control of HIV-1 Infection1 , 2006, The Journal of Immunology.
[57] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[58] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[59] Bette T. Korber,et al. Relative Dominance of Gag p24-Specific Cytotoxic T Lymphocytes Is Associated with Human Immunodeficiency Virus Control , 2006, Journal of Virology.
[60] A. Paradela,et al. Two HLA-B14 Subtypes (B*1402 and B*1403) Differentially Associated with Ankylosing Spondylitis Differ Substantially in Peptide Specificity but Have Limited Peptide and T-cell Epitope Sharing with HLA-B27* , 2005, Journal of Biological Chemistry.
[61] C. Rouzioux,et al. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] Todd M. Allen,et al. Limited Sequence Evolution within Persistently Targeted CD8 Epitopes in Chronic Human Immunodeficiency Virus Type 1 Infection , 2005, Journal of Virology.
[63] Bette Korber,et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.
[64] D. Katzenstein,et al. Hierarchical Targeting of Subtype C Human Immunodeficiency Virus Type 1 Proteins by CD8+ T Cells: Correlation with Viral Load , 2004, Journal of Virology.
[65] Todd M. Allen,et al. HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.
[66] Kenneth A. Taylor,et al. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[67] Kristin Beaudry,et al. Viral Escape from Dominant Simian Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes in DNA-Vaccinated Rhesus Monkeys , 2003, Journal of Virology.
[68] C. Hallahan,et al. The Differential Ability of HLA B*5701+ Long-Term Nonprogressors and Progressors To Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous Viral gag Sequences , 2003, Journal of Virology.
[69] Jeffrey N. Martin,et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.
[70] N. Jones,et al. Evaluation of antigen-specific responses using in vitro enriched T cells. , 2003, Journal of immunological methods.
[71] D. Strick,et al. Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.
[72] T. Ndung’u,et al. Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection , 2003, Journal of Virology.
[73] J. Fernández-Morera,et al. Association of ankylosing spondylitis with HLA-B*1403 in a West African population. , 2002, Arthritis and rheumatism.
[74] C. Hallahan,et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.
[75] M. Mulligan,et al. Magnitude of Functional CD8+ T-Cell Responses to the Gag Protein of Human Immunodeficiency Virus Type 1 Correlates Inversely with Viral Load in Plasma , 2002, Journal of Virology.
[76] B. Walker,et al. Nef-Mediated Resistance of Human Immunodeficiency Virus Type 1 to Antiviral Cytotoxic T Lymphocytes , 2002, Journal of Virology.
[77] Steven M. Wolinsky,et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes , 2002, Nature.
[78] J J Goedert,et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.
[79] E. Rosenberg,et al. Identification of Dominant Optimal HLA-B60- and HLA-B61-Restricted Cytotoxic T-Lymphocyte (CTL) Epitopes: Rapid Characterization of CTL Responses by Enzyme-Linked Immunospot Assay , 2000, Journal of Virology.
[80] F. Marincola,et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[81] S O'Brien,et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. , 1999, Journal of immunology.
[82] B. Walker,et al. Molecular and functional analysis of a conserved CTL epitope in HIV-1 p24 recognized from a long-term nonprogressor: constraints on immune escape associated with targeting a sequence essential for viral replication. , 1999, Journal of immunology.
[83] M A Nowak,et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. , 1998, Science.
[84] B. Walker,et al. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes , 1998, Nature.
[85] R P Johnson,et al. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms , 1997, Journal of virology.
[86] J. Goedert,et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.
[87] B. Walker,et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. , 1996, Journal of immunology.
[88] P. Sansonetti,et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. , 1995, AIDS research and human retroviruses.
[89] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[90] K. Parker,et al. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. , 1994, The Journal of biological chemistry.
[91] B. Walker,et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire , 1994, The Journal of experimental medicine.
[92] P. Parham,et al. B*1401 encodes the B64 antigen: the B64 and B65 splits of B14 differ only at residue 11, a buried amino acid. , 1993, Tissue antigens.
[93] B. Walker,et al. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation , 1992, The Journal of experimental medicine.
[94] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[95] M. A. Saper,et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.
[96] J. Goedert,et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. , 1989, The New England journal of medicine.
[97] P. Parham,et al. Nature of polymorphism in HLA-A, -B, and -C molecules. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[98] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[99] R. Colvin,et al. Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens. , 1987, Journal of immunology.
[100] P. Klenerman,et al. Increasing inflationary T-cell responses following transient depletion of MCMV-specific memory T cells. , 2015, European Journal of Immunology.
[101] The Swiss,et al. Cohort Profile: The Swiss HIV Cohort Study , 2010 .
[102] Nicole Frahm,et al. How to Optimally Define Optimal Cytotoxic T Lymphocyte Epitopes in HIV Infection , 2009 .
[103] David Heckerman,et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.
[104] P. Cresswell,et al. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids , 2004, Immunogenetics.
[105] J. Phair,et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. , 1992, Journal of acquired immune deficiency syndromes.